NASDAQ · INDUSTRIAL ORGANIC CHEMICALS · SMALL CAP
Gevo, Inc. GEVO
19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$160.6M
▲ 849.3% vs FY2024
EPS · FY25
$-0.14
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-7.1%
Net margin · FY25
-21.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 160.6M
Revenue, FY2025 · full 19-year series below
Revenue
Net income
The company lost 21 cents on every revenue dollar this year.
Per share
USD -0.14
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-7.1%
Return on equity, FY2025
ROE
Operating margin-12.6%
Net margin-21.1%
Return on assets-5.2%
Each USD of equity lost 7 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+96.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+415.1%
+96.6%
+18.2%
+16.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.24B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 718.9M
total assets, end of FY2025
Total assetsUSD 718.9M
EquityUSD 466.3M
CashUSD 81.2M
Gross debtUSD 164.8M
Net debtUSD 83.6M
Current ratio1.82×
Net debt stands at 18% of equity.
History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
·
·
Operating income $B
−0.0
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.1
−0.1
−0.0
−0.0
·
·
·
EBITDA $B
0.0
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
·
·
·
·
·
−0.1
−0.0
−0.0
·
·
·
Income tax $B
·
·
·
·
·
0.0
0.0
0.0
·
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.14
−0.34
−0.28
−0.44
−0.30
−0.71
−2.35
−5.74
−30.23
−193.52
−51.61
−153.35
−22.23
−1.86
−2.15
−37.44
−18.07
·
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−7.1
−15.0
−11.4
−17.0
−17.1
−36.7
−35.5
−36.7
−37.1
−63.3
−76.0
−69.8
−79.2
−63.9
−86.0
−228.9
−218.0
−1154.6
·
Shares out B
0.24
0.24
0.24
0.24
0.20
0.13
0.01
0.01
0.00
0.01
0.00
0.01
0.07
0.04
0.03
0.00
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
57 of 59
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 1 failures and 1 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed